Gts Securities LLC Revance Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$2.34 - $4.73 $5,382 - $10,879
-2,300 Reduced 8.01%
26,400 $67,000
Q1 2024

May 15, 2024
BUY
$4.65 - $9.31 $63,705 - $127,547
13,700 Added 91.33%
28,700 $141,000
Q4 2023

Feb 14, 2024
BUY
$5.81 - $11.2 $5,810 - $11,200
1,000 Added 7.14%
15,000 $131,000
Q3 2023

Nov 15, 2023
BUY
$11.47 - $25.07 $160,580 - $350,980
14,000 New
14,000 $160,000

Others Institutions Holding RVNC

# of Institutions
196
Shares Held
81.5M
Call Options Held
490K
Put Options Held
128K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email